ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,466,876, issued on Nov. 11, was assigned to Queen Mary University of London (London).
"Testis development related protein antibodies" was invented by Fulvio D'Acquisto (Greater London, Great Britain).
According to the abstract* released by the U.S. Patent & Trademark Office: "This invention relates to the finding that testis development related protein (TDRP; also termed Immunomoodulin or Imood herein) is a circulatory anxiogenic factor that modulates anxiety-like behaviour in mammalian models through the regulation of the immune system. Methods of treatment of mental disorders, such as anxiety, and TDRP antagonists for use in such methods are provided. Methods of diagnosing or monit...